Source comparison
CJC-1295 No DAC & Ipamorelin Dosage: Protocol Comparison
Clinical Research Standard 100mcg 5 days/week 30–60 min pre-sleep Saturates receptors without receptor downregulation. Ideal for sustained metabolic benefit Performance Research (Advanced) 200mcg 7 days/week Maximal GH amplification. Requires 2-week washout ev
This comparison does not assign a generated winner or score.
- Clinical Research Standard
- 100mcg
- 5 days/week
- 30–60 min pre-sleep
- Saturates receptors without receptor downregulation. Ideal for sustained metabolic benefit
- Performance Research (Advanced)
- 200mcg
- 7 days/week
- Maximal GH amplification. Requires 2-week washout every 12 weeks to prevent tachyphylaxis
- Suboptimal Underdosing
- 50mcg
- Daily
- Variable
- Below receptor saturation threshold. Produces measurable GH elevation but no synergistic amplification
- Excessive Overdosing
- 300mcg+
- GH response plateaus while side effect risk (hyperglycemia, edema) increases. No additional benefit